r.serrano
TL2 · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 13 February 2025 · last posted 12h
79 posts, newest first. Showing up to 150.
-
A promotion I argued against, and why I lost — a second dataset Replied, post #8 · Documentation › Doc review · 27 Jul 2026 · 0 likes A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is not lost.
-
Seven-day rolling means and why weekly readings mislead Replied, post #97 · Outcomes › Progress reports · 24 Jul 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #4 · Sourcing › Red flags · 19 Jul 2026 · 28 likes The number people quote for Distinguishing a red flag is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #76 · Analytics › Home & field testing · 19 Jul 2026 · 21 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. I…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #8 · Clinical › Bloodwork · 17 Jul 2026 · 12 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. Happy to…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #90 · Analytics › Home & field testing · 16 Jul 2026 · 2 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
Historical amylin analogues and what happened to them Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 11 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #19 · Analytics › Mass spectrometry · 12 Jul 2026 · 21 likes Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report showing an unexplained plus twenty-two is usually showing you a…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #143 · Practice › Interactions · 9 Jul 2026 · 2 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
How to ask a question when you cannot say why you are asking it Replied, post #27 · Start Here › How to Ask · 1 Jul 2026 · 0 likes Picking up post #24: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #77 · Devices › Syringes & needles · 19 Jun 2026 · 0 likes Adding the measurement that post #74 says would settle it. An observation about 0.3 ml versus 0.5 ml that I cannot explain and am posting anyway, on the principle that…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #3 · Compounds › Retatrutide · 11 Jun 2026 · 0 likes Glycaemic effects improved rather than worsened in the diabetes work despite the glucagon component, which is the observation that resolves the apparent paradox. It is…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #20 · Practice › Reconstitution · 11 Jun 2026 · 2 likes Adding what did not work for me on Swirling versus inverting versus leaving, since the failures never get written up and they are half the useful information.
-
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Replied, post #2 · Devices › Pens & autoinjectors · 7 Jun 2026 · 15 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Revisiting: The best-written scientific paper you have read Replied, post #18 · Lounge › Off topic · 6 Jun 2026 · 0 likes An observation about best-written scientific paper that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #19 · Evidence › Meta-analyses · 2 Jun 2026 · 22 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #15 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 29 likes Peak-to-trough ratio came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #30 · Compounds › Repair & healing peptides · 23 May 2026 · 6 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #22 · Practice › Storage & stability · 10 May 2026 · 2 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Coming back to: Time to steady state after a dose increase Replied, post #50 · Pharmacology › Pharmacokinetics · 10 May 2026 · 25 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #42 · Evidence › Journal club · 4 May 2026 · 18 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #112 · Practice › Reconstitution · 25 Apr 2026 · 29 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Follow-up: Sleep quality changes during weight loss Replied, post #10 · Wellbeing › Sleep · 25 Apr 2026 · 13 likes I read post #8 twice before replying, because I had assumed the opposite. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #24 · Practice › Reconstitution · 24 Apr 2026 · 23 likes The question underneath 5 mg vial is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect…
-
List price versus negotiated price versus what you pay Replied, post #83 · Access › Pricing · 15 Apr 2026 · 31 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not.
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #15 · Data & Tools › Calculators · 2 Apr 2026 · 25 likes Post #12 answers the question as asked. The question underneath it is different. Significant figures in the output should not exceed what the inputs support. A…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #47 · Practice › Reconstitution · 18 Mar 2026 · 28 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #26 · Lounge › Introductions · 10 Mar 2026 · 0 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community. The short answer was in the…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #3 · Clinical › Comorbidities · 1 Mar 2026 · 3 likes Genuine question rather than a rhetorical one: has anyone here actually observed PCOS and metabolic overlap, as opposed to read about it? The thread is long and I…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #79 · Practice › Storage & stability · 24 Feb 2026 · 0 likes The most useful reply I ever got about storing lyophilised material long term was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #36 · Analytics › Mass spectrometry · 13 Feb 2026 · 4 likes The thing about Adducts that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Trifluoroacetate content and its consequences Replied, post #83 · Analytics › Impurities & related substances · 4 Feb 2026 · 25 likes Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all. A clean-looking table may reflect a high threshold rather than a clean…
-
Waist circumference technique and its repeatability Replied, post #47 · Outcomes › Progress reports · 4 Feb 2026 · 10 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #60 · Sourcing › Vendor reports · 21 Jan 2026 · 1 like The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
-
What to include when your question involves a chromatogram Replied, post #34 · Start Here › How to Ask · 10 Jan 2026 · 13 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context.
-
The headache that turns out to be dehydration Replied, post #111 · Nutrition & Training › Hydration & electrolytes · 26 Dec 2025 · 0 likes On post #109 — agreed on the reasoning, with one qualification. Headache was covered in the wiki last year and the page has a review date on it, which is a better…
-
Reading SURMOUNT-1 without the press release Replied, post #93 · Compounds › Tirzepatide · 8 Dec 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #11 · Compounds › Retatrutide · 25 Nov 2025 · 0 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
-
Request: export my own posts — one year on Replied, post #15 · Meta › Feature requests · 24 Nov 2025 · 0 likes Asking for something deliberately narrow: a way to link to a range of posts rather than a single one. Half the good exchanges here are four posts long and there is no…
-
Reading SURMOUNT-1 without the press release Replied, post #72 · Compounds › Tirzepatide · 20 Nov 2025 · 6 likes Post #71 is right about the mechanism and I think understates the practical bit. The practical version of reading SURMOUNT-1 without the press is three sentences long.…
-
Availability by country, dated, with primary sources Replied, post #55 · Access › International · 11 Nov 2025 · 23 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Thyroid function tests during substantial weight change Replied, post #129 · Clinical › Bloodwork · 10 Nov 2025 · 11 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
The headache that turns out to be dehydration Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 28 Oct 2025 · 0 likes Headache is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Substitution between formats during a shortage Replied, post #80 · Access › Shortages · 22 Oct 2025 · 0 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect.
-
Payment mechanics and the recovery options that do not exist Replied, post #80 · Sourcing › Payments · 22 Oct 2025 · 0 likes Practical experience of payment mechanics, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
When to stop reading forums, including this one Replied, post #31 · Wellbeing › Mental health · 30 Sep 2025 · 0 likes Isolation is a common thread in accounts here and is one of the few things a community can genuinely help with. Worth reading the earlier posts in this thread before…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #57 · Practice › Storage & stability · 27 Sep 2025 · 12 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. Visible particulate is a strong signal in the other direction: it…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #36 · Compounds › Oral incretins · 8 Sep 2025 · 28 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #21 · Evidence › Journal club · 7 Sep 2025 · 15 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #7 · marked as the solution · Practice › Interactions · 23 Aug 2025 · 27 likes Picking up post #4: that is the part I would want checked first. A methods point on Warfarin and altered intake rather than a substantive one: if the comparison is not…
-
What a documentation review can and cannot tell you Replied, post #83 · Sourcing › Independent verification · 21 Aug 2025 · 2 likes Post #80 answers the question as asked. The question underneath it is different. The most useful thing anyone has posted about documentation review in this category was…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #27 · Practice › Storage & stability · 14 Aug 2025 · 14 likes Worth separating two things that post #23 runs together. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
-
A ten-fold dose error caught before injection — one year on Replied, post #146 · Devices › Syringes & needles · 5 Aug 2025 · 1 like Check what the graduations actually say rather than what you expect. A syringe marked in units and one marked in millilitres look similar at a glance and are not the…
-
About the Administration category Replied, post #8 · Practice › Administration · 31 Jul 2025 · 0 likes Post #6 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #21 · Compounds › Secretagogues & GH axis · 29 Jul 2025 · 27 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #90 · Practice › Storage & stability · 18 Jul 2025 · 8 likes Taking post #89 at face value and following it one step further. Trying to state the published stability data actually covers position in a way that someone who…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #61 · Compounds › Semaglutide · 9 Jul 2025 · 25 likes Semaglutide half-life was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #70 · Compounds › Other compounds · 24 Jun 2025 · 31 likes Building on post #68 rather than restating it. I read the earlier replies on research a compound twice before writing this, because I had assumed the opposite and…
-
Pre-registering a personal experiment, seriously Replied, post #56 · Research Methods › N-of-1 designs · 30 May 2025 · 31 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
-
Coming back to: Official shortage notices and what they authorise Replied, post #16 · Access › Shortages · 28 May 2025 · 11 likes Post #12 put the caveat in the right place and I want to underline it. A shortage of one presentation is not a shortage of all of them, and the published notices are…
-
Carryover and the ghost peak from last week's standard Replied, post #70 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 0 likes Where I part company with post #67, and it is a narrow parting. Method validation is the demonstration that a method can separate the compound from its degradation…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #88 · Access › International · 9 Mar 2025 · 2 likes I had written a reply contradicting post #86 and deleted it. Here is what survived. Two questions I would want answered before drawing anything from the Cross-border…
-
Validating a method you did not develop — does this still hold? Replied, post #50 · Analytics › Method validation · 27 Feb 2025 · 8 likes Picking up post #48: that is the part I would want checked first. Specificity: the method can distinguish the intended compound from related impurities and degradation…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #9 · Compounds › Retatrutide · 27 Jan 2025 · 25 likes Narrowing post #8, because the general version has more than one answer. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist.…
-
Protein density versus volume when you cannot eat much Replied, post #24 · Nutrition & Training › Protein & intake · 27 Jan 2025 · 16 likes An update on my earlier protein density versus volume post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #7 · Meta › Wiki maintenance · 22 Jan 2025 · 15 likes Two things can be true about Citation sweep results at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
Criticising the method without criticising the authors Replied, post #32 · Evidence › Study critique · 17 Jan 2025 · 7 likes Post #30 describes the usual case. This is about the unusual one. The reason criticising the method without criticising is hard to answer is that the obvious…
-
Coming back to: When to suspect the method rather than the sample Replied, post #121 · Analytics › Method validation · 23 Dec 2024 · 1 like Sample stability during analysis is part of validation and is routinely ignored. A preparation that degrades in the autosampler over eight hours produces a…
-
Building a sensible monitoring schedule with your prescriber Replied, post #95 · Clinical › Bloodwork · 22 Dec 2024 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Building a sensible monitoring schedule with your prescriber Replied, post #74 · Clinical › Bloodwork · 21 Dec 2024 · 13 likes Worth separating two things that post #72 runs together. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
-
Body image changing more slowly than the body Replied, post #12 · Wellbeing › Mental health · 11 Dec 2024 · 0 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. This is the sort of…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #3 · Practice › Dosing & titration · 8 Dec 2024 · 7 likes Building on the opening post rather than restating it. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #18 · Evidence › Journal club · 24 Nov 2024 · 17 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. A partial…
-
Gallbladder disease risk with rapid weight loss Replied, post #33 · Clinical › Comorbidities · 20 Nov 2024 · 0 likes Post #31 and I disagree about the size of the effect, not about the direction. What I would want before treating gallbladder disease risk as settled: the method, the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #38 · Clinical › Prescriber conversations · 7 Nov 2024 · 0 likes Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than to answer them.
-
Time to steady state after a dose increase Replied, post #151 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes The arithmetic in post #150 is right; the assumption feeding it is the part to check. The accumulation ratio for weekly dosing with a week-long half-life is around two,…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #39 · Clinical › Comorbidities · 15 Oct 2024 · 12 likes Worth separating Hypertension improvement as a question about the compound from Hypertension improvement as a question about the documentation. They get answered by…
-
Irish differences from the UK position Replied, post #26 · Regional › UK & Ireland · 7 Oct 2024 · 24 likes Post #24 and I disagree about the size of the effect, not about the direction. Pharmacy practice varies between pharmacies and is not deducible from the regulatory…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #30 · Nutrition & Training › Hydration & electrolytes · 7 Aug 2024 · 20 likes The most useful posts here describe what was measured, what was changed, and what happened, in that order.